Published in J Parasitol on June 01, 1984
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
Target-cell-specific facilitation and depression in neocortical circuits. Nat Neurosci (1998) 4.88
Salient features of synaptic organisation in the cerebral cortex. Brain Res Brain Res Rev (1998) 4.65
Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. Science (1986) 4.40
Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet (1992) 4.32
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci U S A (1998) 3.93
Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron (1998) 3.90
Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia. Lancet (1992) 3.51
Development of indicators to assess hunger. J Nutr (1990) 3.44
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 3.26
Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet (1979) 3.22
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
Self-treatment of malaria in a rural area of western Kenya. Bull World Health Organ (1995) 3.03
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology (1974) 2.87
Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ (1997) 2.73
Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology (2002) 2.67
Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis (1993) 2.52
Within month variability in use of soup kitchens in New York State. p4. Am J Public Health (1988) 2.43
The indirect fluorescent antibody test for malaria. Am J Trop Med Hyg (1972) 2.37
Identification of Plasmodium vivax-like human malaria parasite. Lancet (1993) 2.37
Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg (1996) 2.34
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980. Lancet (1981) 2.32
Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature (1986) 2.19
Long-term malaria prophylaxis with weekly mefloquine. Lancet (1993) 2.09
Neurologic reactions after a therapeutic dose of mefloquine. N Engl J Med (1989) 2.03
Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology (1999) 2.02
Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg (1986) 2.01
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis (2001) 1.94
Combating severe malaria in African children. Bull World Health Organ (1988) 1.94
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. JAMA (1991) 1.90
Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med (1989) 1.88
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg (1982) 1.85
Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res (1981) 1.80
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78
An epidemiologic study of the benefits and risks of running. JAMA (1982) 1.76
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg (2001) 1.75
Varying virulence in rabbits infected with different filamentous types of Histoplasma capsulatum. J Bacteriol (1968) 1.73
Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis (1992) 1.73
Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet (1991) 1.72
Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies. JAMA (1991) 1.70
In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age. Am J Trop Med Hyg (1986) 1.65
Malaria sporozoite penetration. A new approach by double staining. J Immunol Methods (1988) 1.65
Studies on the transmission of simian malarias. II. Transmission of the H strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. J Parasitol (1967) 1.63
Mosquito-transmitted malaria in New York City, 1993. Lancet (1995) 1.63
CHLORAMPHENICOL (CHLOROMYCETIN) IN EXPERIMENTAL CHOLERA INFECTIONS. J Bacteriol (1949) 1.59
Geographic subdivision of the range of the malaria parasite Plasmodium vivax. Emerg Infect Dis (2001) 1.59
Plasmodium malariae blood-stage dynamics. J Parasitol (2001) 1.59
Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun (1975) 1.57
Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol Phylogenet Evol (1996) 1.56
Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology (2001) 1.55
Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun (2000) 1.54
Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1985) 1.50
The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg (1992) 1.49
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J Comp Neurol (1989) 1.46
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. Mol Cell Probes (1995) 1.46
Fluorescent antibody studies in human malaria. IV. Cross-reactions between human and simian malaria. Am J Trop Med Hyg (1966) 1.46
Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand. Lancet (1981) 1.43
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science (1991) 1.43
The development of a surveillance system to monitor emergency food relief in New York State. Am J Public Health (1987) 1.42
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg (1995) 1.39
The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience (1987) 1.37
Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ (1984) 1.36
Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. Nat New Biol (1972) 1.36
Studies on the persistence of malarial antibody response. Am J Epidemiol (1968) 1.35
Decreased regional brain metabolism after ect. Am J Psychiatry (2001) 1.33
Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS (1997) 1.32
Studies on the characterization of plasmodium vivax strains from Central America. Am J Trop Med Hyg (1972) 1.32
Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J Immunol (2001) 1.31
Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg (1996) 1.31
Fatal malaria in US civilians. Lancet (1985) 1.30
Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1993) 1.30
In-vivo and in-vitro assessment of chloroquine-resistant Plasmodium falciparum malaria in Zanzibar. Lancet (1983) 1.27
Overweight schoolchildren in New York State: prevalence and characteristics. Am J Public Health (1994) 1.27
Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. Mol Biochem Parasitol (1992) 1.27
Assessment of chloroquine sensitivity of Plasmodium falciparum in Choluteca, Honduras. Bull World Health Organ (1981) 1.25
Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship. Proc Natl Acad Sci U S A (2001) 1.25
Excitotoxic mechanisms of epileptic brain damage. Adv Neurol (1986) 1.24
Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai. Exp Parasitol (1988) 1.24
No place to unload: a preliminary analysis of the prevalence, risk factors, and consequences of ambulance diversion. Ann Emerg Med (1994) 1.24
Relative importance of risk factors in bladder carcinogenesis. J Chronic Dis (1978) 1.23
High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya. N Engl J Med (1982) 1.23
Neisseria lactamica and Neisseria polysaccharea as possible sources of meningococcal beta-lactam resistance by genetic transformation. Antimicrob Agents Chemother (1990) 1.22
Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. Am J Trop Med Hyg (1980) 1.20
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A (1999) 1.19
Use of prophylaxis for malaria by American travelers to Africa and Haiti. JAMA (1987) 1.19
Malaria incidence and prevention among European and North American travellers to Kenya. Bull World Health Organ (1990) 1.19
Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from nonhuman primate blood using Percoll gradients. Am J Trop Med Hyg (1986) 1.19
Disease-surveillance and decision-making after the 1976 Guatemala earthquake. Lancet (1977) 1.17